Pinegrove Credit Partners has formed a strategic partnership with Temasek to provide venture debt financing to growth-stage companies in the “innovation economy”.
Together, global investment firm Temasek and Pinegrove, which is the venture debt and private credit business of Pinegrove backed by Brookfield and HRTG Partners, will extend flexible, minimally dilutive financing solutions to growth-stage technology and life sciences companies.
Read more: Nuveen, Hunter Point and Temasek enter strategic partnership
Pinegrove Credit Partners offers secured loans to venture capital-backed companies operating in the innovation economy, including AI and compute infrastructure, defence, space, energy and robotics technologies, as well as enterprise software, healthcare and life sciences.
Since 2012, Pinegrove has worked alongside Silicon Valley Bank’s venture lending platform and, in December 2024, the two firms entered a strategic lending relationship.
Established in 2012, Pinegrove Credit Partners’ funds have since deployed more than $4.5bn (£3.4bn) across approximately 580 loans to over 450 growth-stage companies.
Existing fund vehicles have closed or signed term sheets on 37 loans, totalling approximately $700m in commitments since March 2025.
Read more: Barclays backs £150m venture debt fund
“Pinegrove’s platform is built on deep connectivity across the innovation ecosystem, including long-standing relationships with banking partners, sponsors, and company leadership teams,” said Jim Ellison, managing partner and head of Pinegrove Credit Partners. “This positioning drives differentiated origination and allows us to deploy capital with a high degree of selectivity.”
Singapore-headquartered Temasek has a net portfolio value of S$434bn (£254.1bn) and operates 13 offices in nine countries.
